NCT03882840View on ClinicalTrials.gov

Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 1, 2028

Study Completion Date

January 1, 2035

Conditions
Anti-cancer Cell ImmunotherapyT Cell and NK Cell
Interventions
BIOLOGICAL

ITNK cell therapy

Infusion of ITNK/CAR-ITNK cells

Trial Locations (1)

510260

RECRUITING

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
collaborator

Hunan Zhaotai Yongren Medical Innovation Co. Ltd.

OTHER

lead

Second Affiliated Hospital of Guangzhou Medical University

OTHER